table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Personalized Cancer Vaccines Market Size Analysis from 2023 to 2028
1.5.1 Global Personalized Cancer Vaccines Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Personalized Cancer Vaccines Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Personalized Cancer Vaccines Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Personalized Cancer Vaccines Industry Impact
Chapter 2 Global Personalized Cancer Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Personalized Cancer Vaccines (Volume and Value) by Type
2.1.1 Global Personalized Cancer Vaccines Consumption and Market Share by Type (2017-2022)
2.1.2 Global Personalized Cancer Vaccines Revenue and Market Share by Type (2017-2022)
2.2 Global Personalized Cancer Vaccines (Volume and Value) by Application
2.2.1 Global Personalized Cancer Vaccines Consumption and Market Share by Application (2017-2022)
2.2.2 Global Personalized Cancer Vaccines Revenue and Market Share by Application (2017-2022)
2.3 Global Personalized Cancer Vaccines (Volume and Value) by Regions
2.3.1 Global Personalized Cancer Vaccines Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Personalized Cancer Vaccines Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Personalized Cancer Vaccines Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Personalized Cancer Vaccines Consumption by Regions (2017-2022)
4.2 North America Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
4.10 South America Personalized Cancer Vaccines Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Personalized Cancer Vaccines Market Analysis
5.1 North America Personalized Cancer Vaccines Consumption and Value Analysis
5.1.1 North America Personalized Cancer Vaccines Market Under COVID-19
5.2 North America Personalized Cancer Vaccines Consumption Volume by Types
5.3 North America Personalized Cancer Vaccines Consumption Structure by Application
5.4 North America Personalized Cancer Vaccines Consumption by Top Countries
5.4.1 United States Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
5.4.2 Canada Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
5.4.3 Mexico Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 6 East Asia Personalized Cancer Vaccines Market Analysis
6.1 East Asia Personalized Cancer Vaccines Consumption and Value Analysis
6.1.1 East Asia Personalized Cancer Vaccines Market Under COVID-19
6.2 East Asia Personalized Cancer Vaccines Consumption Volume by Types
6.3 East Asia Personalized Cancer Vaccines Consumption Structure by Application
6.4 East Asia Personalized Cancer Vaccines Consumption by Top Countries
6.4.1 China Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
6.4.2 Japan Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
6.4.3 South Korea Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 7 Europe Personalized Cancer Vaccines Market Analysis
7.1 Europe Personalized Cancer Vaccines Consumption and Value Analysis
7.1.1 Europe Personalized Cancer Vaccines Market Under COVID-19
7.2 Europe Personalized Cancer Vaccines Consumption Volume by Types
7.3 Europe Personalized Cancer Vaccines Consumption Structure by Application
7.4 Europe Personalized Cancer Vaccines Consumption by Top Countries
7.4.1 Germany Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.2 UK Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.3 France Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.4 Italy Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.5 Russia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.6 Spain Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.7 Netherlands Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.8 Switzerland Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
7.4.9 Poland Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 8 South Asia Personalized Cancer Vaccines Market Analysis
8.1 South Asia Personalized Cancer Vaccines Consumption and Value Analysis
8.1.1 South Asia Personalized Cancer Vaccines Market Under COVID-19
8.2 South Asia Personalized Cancer Vaccines Consumption Volume by Types
8.3 South Asia Personalized Cancer Vaccines Consumption Structure by Application
8.4 South Asia Personalized Cancer Vaccines Consumption by Top Countries
8.4.1 India Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
8.4.2 Pakistan Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Personalized Cancer Vaccines Market Analysis
9.1 Southeast Asia Personalized Cancer Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Personalized Cancer Vaccines Market Under COVID-19
9.2 Southeast Asia Personalized Cancer Vaccines Consumption Volume by Types
9.3 Southeast Asia Personalized Cancer Vaccines Consumption Structure by Application
9.4 Southeast Asia Personalized Cancer Vaccines Consumption by Top Countries
9.4.1 Indonesia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.2 Thailand Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.3 Singapore Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.4 Malaysia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.5 Philippines Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.6 Vietnam Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
9.4.7 Myanmar Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 10 Middle East Personalized Cancer Vaccines Market Analysis
10.1 Middle East Personalized Cancer Vaccines Consumption and Value Analysis
10.1.1 Middle East Personalized Cancer Vaccines Market Under COVID-19
10.2 Middle East Personalized Cancer Vaccines Consumption Volume by Types
10.3 Middle East Personalized Cancer Vaccines Consumption Structure by Application
10.4 Middle East Personalized Cancer Vaccines Consumption by Top Countries
10.4.1 Turkey Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.3 Iran Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.5 Israel Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.6 Iraq Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.7 Qatar Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.8 Kuwait Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
10.4.9 Oman Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 11 Africa Personalized Cancer Vaccines Market Analysis
11.1 Africa Personalized Cancer Vaccines Consumption and Value Analysis
11.1.1 Africa Personalized Cancer Vaccines Market Under COVID-19
11.2 Africa Personalized Cancer Vaccines Consumption Volume by Types
11.3 Africa Personalized Cancer Vaccines Consumption Structure by Application
11.4 Africa Personalized Cancer Vaccines Consumption by Top Countries
11.4.1 Nigeria Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
11.4.2 South Africa Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
11.4.3 Egypt Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
11.4.4 Algeria Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
11.4.5 Morocco Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 12 Oceania Personalized Cancer Vaccines Market Analysis
12.1 Oceania Personalized Cancer Vaccines Consumption and Value Analysis
12.2 Oceania Personalized Cancer Vaccines Consumption Volume by Types
12.3 Oceania Personalized Cancer Vaccines Consumption Structure by Application
12.4 Oceania Personalized Cancer Vaccines Consumption by Top Countries
12.4.1 Australia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
12.4.2 New Zealand Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 13 South America Personalized Cancer Vaccines Market Analysis
13.1 South America Personalized Cancer Vaccines Consumption and Value Analysis
13.1.1 South America Personalized Cancer Vaccines Market Under COVID-19
13.2 South America Personalized Cancer Vaccines Consumption Volume by Types
13.3 South America Personalized Cancer Vaccines Consumption Structure by Application
13.4 South America Personalized Cancer Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.2 Argentina Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.3 Columbia Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.4 Chile Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.5 Venezuela Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.6 Peru Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
13.4.8 Ecuador Personalized Cancer Vaccines Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Personalized Cancer Vaccines Business
14.1 Advaxis Inc
14.1.1 Advaxis Inc Company Profile
14.1.2 Advaxis Inc Personalized Cancer Vaccines Product Specification
14.1.3 Advaxis Inc Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Genocea
14.2.1 Genocea Company Profile
14.2.2 Genocea Personalized Cancer Vaccines Product Specification
14.2.3 Genocea Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 BioNtech
14.3.1 BioNtech Company Profile
14.3.2 BioNtech Personalized Cancer Vaccines Product Specification
14.3.3 BioNtech Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Personalis
14.4.1 Personalis Company Profile
14.4.2 Personalis Personalized Cancer Vaccines Product Specification
14.4.3 Personalis Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Genetech
14.5.1 Genetech Company Profile
14.5.2 Genetech Personalized Cancer Vaccines Product Specification
14.5.3 Genetech Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Hoffmann-La Roche Ltd
14.6.1 Hoffmann-La Roche Ltd Company Profile
14.6.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Specification
14.6.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 ISA Pharmaceuticals
14.7.1 ISA Pharmaceuticals Company Profile
14.7.2 ISA Pharmaceuticals Personalized Cancer Vaccines Product Specification
14.7.3 ISA Pharmaceuticals Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 CureVac AG
14.8.1 CureVac AG Company Profile
14.8.2 CureVac AG Personalized Cancer Vaccines Product Specification
14.8.3 CureVac AG Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Celldex
14.9.1 Celldex Company Profile
14.9.2 Celldex Personalized Cancer Vaccines Product Specification
14.9.3 Celldex Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Gritstone Oncology
14.10.1 Gritstone Oncology Company Profile
14.10.2 Gritstone Oncology Personalized Cancer Vaccines Product Specification
14.10.3 Gritstone Oncology Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Merck
14.11.1 Merck Company Profile
14.11.2 Merck Personalized Cancer Vaccines Product Specification
14.11.3 Merck Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Moderna Therapeutics
14.12.1 Moderna Therapeutics Company Profile
14.12.2 Moderna Therapeutics Personalized Cancer Vaccines Product Specification
14.12.3 Moderna Therapeutics Personalized Cancer Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Personalized Cancer Vaccines Market Forecast (2023-2028)
15.1 Global Personalized Cancer Vaccines Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Personalized Cancer Vaccines Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Personalized Cancer Vaccines Value and Growth Rate Forecast (2023-2028)
15.2 Global Personalized Cancer Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Personalized Cancer Vaccines Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Personalized Cancer Vaccines Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Personalized Cancer Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Personalized Cancer Vaccines Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Personalized Cancer Vaccines Consumption Forecast by Type (2023-2028)
15.3.2 Global Personalized Cancer Vaccines Revenue Forecast by Type (2023-2028)
15.3.3 Global Personalized Cancer Vaccines Price Forecast by Type (2023-2028)
15.4 Global Personalized Cancer Vaccines Consumption Volume Forecast by Application (2023-2028)
15.5 Personalized Cancer Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
